Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences

Radnor, Pa. — January 29^th, 2025 — Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ（Nasdaq：CERT) はCERT), a global leader in model-informed drug development, today announced that it will release financial results for the fourth quarter and full year of 2024 after the market close on Wednesday, February 26^th, 2025. 同社経営陣は、同日午後 5 時 (米国東部時間) から決算説明会を開催し、決算について説明します。

Investors interested in listening to the conference call are required to register online. 少なくとも 前日までにご登録いただくことをお勧めしております。

Certara also announced that company management will participate in the following investor conferences:

• Leerink Partners Global Healthcare Conference
  Date and Time: Tuesday, March 11^th at 1:00PM ET
• Barclays 27^th Annual Global Healthcare Conference
  Date and Time: Wednesday, March 12^th at 11:30AM ET

Live and archived webcasts of these events will be available on the “Investors” section of the Certara website at https://ir.certara.com/.